asp8232
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2013 (NCT02218099)
Timeline
Indications
Mechanism of action
- Amine oxidase, copper containingINHIBITOR
AOC3 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- asp8232
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02358096 | Phase 2 | Feb 1, 2015 | Astellas |
| NCT02302079 | Phase 2 | Jan 1, 2015 | Astellas |
| NCT02218099 | Phase 1/Phase 2 (Phase 2) | Sep 1, 2013 | Astellas |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Astellas | For profit | 3 | 3 | 1 | 2013 |
1 organizations
Page 1 / 1